AMG-732

N/A

Report date: 2026/05/16 20:00:17

Base Information

Drug NameAMG-732
Drug Alias NameAMG732AMG-732AMG 732HZN-280
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionAnti-Insulin-like growth factor I receptor
TargetsInsulin-like growth factor I receptor
Therapy Area/IndicationsGraves Ophthalmopathy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSingapore +[12
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesAmgen Inc
Inactive CompaniesN/A
Active IndicationsGraves Ophthalmopathy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A